Researchers at Durham have helped unlock a new understanding of how bacteria import antimicrobial peptides—the molecules that can kill or inhibit microbes. The research sheds new light on SbmA, a key ...

Adding an extra antibiotic powder doesn't further reduce a person's risk of infection during surgery to repair complex bone ...

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility ...

Lone Star ticks that spread alpha gal syndrome are expanding their range alongside other ticks. Here's what to know.

The FDA revealed that a batch of raw cheddar cheese sold by RAW FARM had tested positive for E. coli.

Highlights include pooled safety findings from Paratek's Phase 3 studies in community acquired pneumonia (CABP) and acute bacterial skin and skin structure infection (ABSSSI), as well as additional ...

Acurx Pharmaceuticals, Inc. ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today ...

Qiagen is moving into syndromic testing for bloodstream infections with the launch of the Netherlands-based diagnostics maker ...

Highlights include pooled safety findings from Paratek’s Phase 3 studies in community acquired pneumonia (CABP) and acute bacterial skin and skin ...

Q-linea AB (publ) (OMX: QLINEA) today announces the company has received 510(k) clearance from the US FDA for its expanded ASTar® Gram-negative Blood Culture menu. The expanded panel represents a sign ...

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...

Longhorn Vaccines and Diagnostics (LHNVD), an IND enabling-stage biopharmaceutical company, today announced it will present new preclinical data demonstrating that DRG5--BD11, a novel human bispecific ...